Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Science Advances|December 4, 2024
A trafficking regulatory subnetwork governs α<sub>V</sub>β<sub>6</sub> integrin-HER2 cross-talk to control breast cancer invasion and drug resistanceHoracio Maldonado, Marcel Dreger, Lara D Bedgood, et al.Cancer Discovery|November 20, 2023
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast CancerBelinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, et al.The Lancet. Oncology|July 2, 2019
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion studyUdai Banerji, Carla M L van Herpen, Cristina Saura, et al.Neuron|December 27, 2008
Genomic anatomy of the hippocampusCarol L Thompson, Sayan D Pathak, Andreas Jeromin, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim TrialPeter S Hall, Alison Smith, Claire Hulme, et al.Circulation. Heart Failure|June 29, 2022
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline CardiotoxicityPeter A Henriksen, Peter Hall, Olga Oikonomidou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH TrialIseult M Browne, Javier Pascual, Rosalind J Cutts, et al.Nature Communications|June 10, 2022
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.Journal of the National Cancer Institute|May 1, 2016
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the OthersJohn M S Bartlett, Jane Bayani, Andrea Marshall, et al.Nature Communications|December 1, 2018
Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levelsDavid Novo, Nikki Heath, Louise Mitchell, et al.Pageof 15